Test Overview
Test Methodology

Next generation sequencing

Test Usage

Evaluation of hematologic neoplasms, specifically of myeloid origin (eg, acute myeloid leukemia, myelodysplastic syndrome, myeloproliferative neoplasm, myelodysplastic/myeloproliferative neoplasm) at the time of diagnosis or possibly disease relapse, to help determine diagnostic classification and provide prognostic or therapeutic information for clinical management

Reference Range *

An interpretive report is provided

Test Details
Days Set Up
Monday, Wednesday, Friday
Analytic Time

15 - 22 days

Soft Order Code
NGSHM
Laboratory
Sendout
Reference Laboratory
Mayo NGSHM
Section
Special Testing
Specimen Requirements
Collection Instructions

Collect specimen in an EDTA or ACD tube and send to Specimen Processing at room temperature. (refrigerated acceptable)

Alternate Specimen
Heparin specimens are acceptable, but not preferred. Ambient is preferred, but refrigerated is acceptable.
Extracted DNA is acceptable (send frozen/refrig/ambient)
Normal Volume
2 mL Whole blood, or bone marrow
Minimum Volume
1 mL Whole blood, or bone marrow
Billing
CPT Code
81450
NY State Approved
No